Login to Your Account

Ruiyi, Ihuman GPCR partnership exploits 'classic Chinese scale'

By Marie Powers
Staff Writer

Wednesday, June 11, 2014

Ruiyi Inc. and the Ihuman Institute forged a research collaboration allowing the upstart educational institution, housed at China's Shanghaitech University, to apply the company's intermembranous conformation antigen presenting system technology for the creation of  MAbs that specifically bind to GPCR.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription